(Q44102929)

reason for preferred rank

29 November 2017

title

4-pregnene-3-one-20β-carboxaldehyde: A potent inhibitor of 17α-hydroxylase/C17,20-lyase and of 5α-reductase (English)

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

14 October 2022

4-pregnene-3-one-20 beta-carboxaldehyde: a potent inhibitor of 17 alpha-hydroxylase/C17,20-lyase and of 5 alpha-reductase (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1606043

cytochrome P-450 enzyme inhibitors

14 October 2022

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1606043

14 October 2022

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

14 October 2022

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

14 October 2022

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

14 October 2022

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

14 October 2022

author name string

J. Li

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1606043

14 October 2022

Y. Li

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1606043

14 October 2022

C. Son

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1606043

14 October 2022

P. Banks

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1606043

14 October 2022

A. Brodie

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1606043

14 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1606043

14 October 2022

publication date

1 May 1992

1 reference

full work available at URL

29 November 2017

https://api.elsevier.com/content/article/PII:0960076092901345?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

https://api.elsevier.com/content/article/PII:0960076092901345?httpAccept=text/plain

14 October 2022

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

The Journal of Steroid Biochemistry and Molecular Biology

14 October 2022

published in

1 reference

29 November 2017

volume

42

1 reference

29 November 2017

issue

3-4

1 reference

29 November 2017

page(s)

313-320

1 reference

Inhibition of 17 alpha-hydroxylase/C17-C20 lyase by bifluranol and its analogues

29 November 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

Inhibition of enzymes of estrogen and androgen biosynthesis by esters of 4-pyridylacetic acid

14 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

Hydroxyperfluoroazobenzenes: novel inhibitors of enzymes of androgen biosynthesis

14 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

Inhibition of testicular 17 alpha-hydroxylase and 17,20-lyase but not 3 beta-hydroxysteroid dehydrogenase-isomerase or 17 beta-hydroxysteroid oxidoreductase by ketoconazole and other imidazole drugs.

14 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

Inhibitory effect and interaction of stanozolol with pig testicular cytochrome P-450 (17 alpha-hydroxylase/C17,20-lyase)

14 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

17 beta-(cyclopropylamino)-androst-5-en-3 beta-ol, a selective mechanism-based inhibitor of cytochrome P450(17 alpha) (steroid 17 alpha-hydroxylase/C17-20 lyase).

14 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

Mechanism of inhibition of human testicular steroidogenesis by oral ketoconazole

14 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

Ketoconazole Therapy in Advanced Prostatic Cancer

14 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

Objective responses to ketoconazole therapy in patients with relapsed progressive prostatic cancer

14 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

The Effect of an Aromatase Inhibitor, 4-Hydroxy-4-Androstene- 3,17-Dione, On Estrogen-Dependent Processes in Reproduction and Breast Cancer11

14 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

Lack of evidence for aromatase in human prostatic tissues: effects of 4-hydroxyandrostenedione and other inhibitors on androgen metabolism

14 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

Protein measurement with the Folin phenol reagent

14 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

Regulation of ovarian steroid biosynthesis by estrogen during proestrus in the rat.

14 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

The influence of progesterone on the conversion of 17-hydroxyprogesterone to testosterone in the mouse testis

14 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

Microsomal cytochrome P-450 from neonatal pig testis: two enzymatic activities (17 alpha-hydroxylase and c17,20-lyase) associated with one protein

14 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

Hormonal effects of ketoconazole in vivo in the male rat: mechanism of action

14 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

Response of Rat Ventral Prostate to a New and Novel 5αa-Reductase Inhibitor

14 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

The clinical development of a 5α-reductase inhibitor, finasteride

14 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer

14 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

The effects of aminoglutethimide and hydrocortisone, alone and combined, on androgen levels in post-orchiectomy prostatic cancer patients

14 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0960-0760(92)90134-5

14 October 2022

Identifiers

1 reference

29 November 2017

1 reference